Cells in the tumour and its microenvironment benefit from these immunological safeguards by producing excessive amounts of immunosuppressive cytokines, such as TGFβ (Flavell et al., 2010; Batlle and Massagué, 2019). Here, TGFB1 is linked to neoplasm.